Actively Recruiting
Study to Predict Blood Clotting and Bleeding Risks in Adults With Chronic Kidney Disease and Acute Heart Problems Using New Blood Tests
Led by Assistance Publique Hopitaux De Marseille · Updated on 2023-10-27
850
Participants Needed
1
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating two new biomarker tests to better predict blood clotting and bleeding risks in adults with stage 3A or more severe chronic kidney disease CKD who have experienced an acute coronary syndrome ACS and undergone percutaneous coronary intervention PCI. The study aims to improve how antiplatelet therapy is tailored for each patient to reduce these risks. This project is part of the RHU INNOV-CKD initiative and involves collaboration with industry partners to develop automated methods for measuring these biomarkers. The study involves collecting blood samples at specific times 12 to 24 hours after a P2Y12 ADP receptor loading dose and again one month after PCI. These tests focus on two biomarkers active Rap1b in platelets and the pro-antithrombotic balance of circulating endothelial microvesicles, which reflect how well the blood vessels are functioning. These measurements will be used to assess the risk of clotting and bleeding. Participants will be monitored over time, with the main outcome being how well high levels of active Rap1b predict risk at 12 months. Additional measurements of the biomarkers will be taken at 1 and 6 months to track changes. Throughout the study, researchers will evaluate these markers to understand their relationship with thrombotic and hemorrhagic events, aiming to improve personalized treatment. The study is expected to continue until December 2026.
CONDITIONS
Brief Title
Evaluation of the Effectiveness of Platelet-based and Microvesicle-based Assays to Predict Thrombotic and Bleeding Risk in Chronic Kidney Disease Patients With Acute Coronary Syndrome
Research Team
L
LAURENT BONELLO
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here